250 related articles for article (PubMed ID: 23292829)
1. Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma.
Lu JW; Lin YM; Chang JG; Yeh KT; Chen RM; Tsai JJ; Su WW; Hu RM
Med Oncol; 2013 Mar; 30(1):379. PubMed ID: 23292829
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
Chen XQ; He JR; Wang HY
Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma.
Kim H; Lee MJ; Kim MR; Chung IP; Kim YM; Lee JY; Jang JJ
Liver; 2000 Apr; 20(2):173-8. PubMed ID: 10847487
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M
Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
7. [Correlations of expressions of macrophage migration inhibitor factor and cyclin D1 with tumor size and metastasis of hepatocellular carcinoma].
Xia JT; Li W; Liu YJ; Chen LZ; Wu ZF; Zhang LJ; Wang Q
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):918-21. PubMed ID: 18171527
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY
Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
[TBL] [Abstract][Full Text] [Related]
10. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
[TBL] [Abstract][Full Text] [Related]
11. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
[TBL] [Abstract][Full Text] [Related]
12. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer.
Peurala E; Koivunen P; Haapasaari KM; Bloigu R; Jukkola-Vuorinen A
Breast Cancer Res; 2013 Jan; 15(1):R5. PubMed ID: 23336272
[TBL] [Abstract][Full Text] [Related]
15. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma.
Peng SY; Chou SP; Hsu HC
J Hepatol; 1998 Aug; 29(2):281-9. PubMed ID: 9722210
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma.
Kong J; Zhou X; Liu S; Jin T; Piao Y; Liu C; Lin Z
Int J Clin Exp Pathol; 2014; 7(6):3018-27. PubMed ID: 25031720
[TBL] [Abstract][Full Text] [Related]
17. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma.
Matsumoto M; Furihata M; Ishikawa T; Ohtsuki Y; Ogoshi S
Br J Cancer; 1999 Apr; 80(1-2):256-61. PubMed ID: 10390005
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
Ding Y; Chen B; Wang S; Zhao L; Chen J; Ding Y; Chen L; Luo R
Int J Cancer; 2009 Feb; 124(3):653-8. PubMed ID: 18972435
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity.
Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I
J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344
[TBL] [Abstract][Full Text] [Related]
20. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
